ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

IDD Innate Pharma

2.13
0.075 (3.65%)
22 Jul 2024 - Closed
Realtime Data
Share Name Share Symbol Market Type
Innate Pharma TG:IDD Tradegate Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.075 3.65% 2.13 2.11 2.15 2.13 2.06 2.06 491 20:59:22

Disposal

13/01/2004 2:36pm

UK Regulatory


RNS Number:1781U
ID Data PLC
13 January 2004

                    ID Data plc ("ID Data" or the "Company")

                         Disposal of Equity Investment

ID Data is pleased to announce that on 9 January 2004 the Company disposed of
2,000,000 Ordinary Shares of 5p each in New Opportunities Investment Trust plc
("NOIT") for a consideration of #1,097,800.  The disposal represents a premium
of #97,800 to the written down carrying value of the investment in the Company's
interim results for the six months to 30 September 2003.

This sale represents the total holding of ID Data and thus the Company no longer
has a notifiable interest in the issued share capital of NOIT, however ID Data
continues to hold 400,000 warrants in NOIT, which are exercisable at #1.00, at a
nil carrying value.



For further information, please contact:
ID Data plc
Peter Cox                                Tel: +44 (0) 1536 207000
enquiries@id-data.co.uk

Durlacher Limited
Anthony Schia                            Tel: +44 (20) 7459 3600


Notes to Editors:

ID Data plc ("ID Data") is the world's seventh-largest supplier of
secure-transaction systems and smart-card services to the international
telephony, banking, retail, and secure-access sectors. The Company's strategy,
to move from commodity products to value-added services and solutions, has
created a solid platform on which to build further growth. The Company's clients
include Vodafone, Nectar, Tesco, the Automobile Association, Exxon Mobil and, in
Poland, the Premium Club loyalty card scheme. ID Data has formed agreements with
major global corporations to facilitate rapid market development including
partnerships with Toshiba and Toppan. The Company has delivered in excess of 10
million chip cards to the banking market in the UK. The Company was founded in
1988 and was listed on the AIM market of the London Stock Exchange in October
2000.

www.id-data.co.uk


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

DISEALFDFDDLEFE

1 Year Innate Pharma Chart

1 Year Innate Pharma Chart

1 Month Innate Pharma Chart

1 Month Innate Pharma Chart